Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3151 AL 3165

Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease

Heiss JD, Ray-Chaudhury A, Kleiner DE, Ehrlich DJ, Scott G, Edwards NA, Goldstein DS, Hammoud DA, Hadaczek P, Van Laar VS, Graff SA, Herscovitch P, Lungu C, Hallett M, Lonser RR, Zaghloul KA, Bankiewicz KS.

Mov Disord. 2024 Aug;39(8):1412-1417. doi: 10.1002/mds.29820. Epub 2024 May 8.

Microstructural changes in the inferior tuberal hypothalamus correlate with daytime sleepiness in Lewy body disease

Cohen JS, Radhakrishnan H, Olm CA, Das SR, Cook PA, Wolk DA, Weintraub D, Irwin DJ, McMillan CT.

medRxiv [Preprint]. 2024 Aug 16:2024.08.16.24312102. doi: 10.1101/2024.08.16.24312102.

"Advanced" Parkinson's disease: A review

Aslam S, Manfredsson F, Stokes A, Shill H.

Parkinsonism Relat Disord. 2024 Jun;123:106065. doi: 10.1016/j.parkreldis.2024.106065. Epub 2024 Feb 23.

[Visual impairment in Parkinson’s disease]

Dalbro SEJ, Kerty E.

Tidsskr Nor Laegeforen. 2024 Apr 2;144(6). doi: 10.4045/tidsskr.23.0716. Print 2024 May 14.

Voice self-assessment in individuals with Parkinson's Disease as compared to general voice disorders

Contreras-Ruston F, Castillo-Allendes A, Saavedra-Garrido J, Ochoa-Muñoz AF, Hunter EJ, Kotz SA, Navarra J.

Parkinsonism Relat Disord. 2024 Jun;123:106944. doi: 10.1016/j.parkreldis.2024.106944. Epub 2024 Mar 22.

Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson's Disease: findings from the UK Biobank

Acquah A, Creagh A, Hamy V, Shreves A, Zisou C, Harper C, Van Duijvenboden S, Antoniades C, Bennett D, Clifton D, Doherty A.

medRxiv [Preprint]. 2024 Aug 14:2024.08.13.24311539. doi: 10.1101/2024.08.13.24311539.

A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson's disease

Chen X, Zhang Y.

Neural Regen Res. 2024 Feb;19(2):324-330. doi: 10.4103/1673-5374.379042.

Generation of an induced pluripotent stem cell line (HMSCATi004-A) from an early onset Parkinson's disease patient with PRKN gene mutation

Cheng J, Zhai Y, Guo X, Wang X, Ma M, Ren X, Wang S, Cui H, Ren Q.

Stem Cell Res. 2024 Dec;81:103578. doi: 10.1016/j.scr.2024.103578. Epub 2024 Oct 9.

The gut-brain axis in Parkinson's disease

Bonaz B.

Rev Neurol (Paris). 2024 Jan-Feb;180(1-2):65-78. doi: 10.1016/j.neurol.2023.11.004. Epub 2023 Dec 20.

Focused ultrasound therapy: Back to the future

Verhagen Metman L, Monje MHG, Obeso JA, Martínez-Fernández R.

Parkinsonism Relat Disord. 2024 Apr;121:106023. doi: 10.1016/j.parkreldis.2024.106023. Epub 2024 Feb 1.

Aspartame use and Parkinson's disease: review of associated effects on neurotransmitters, oxidative stress, and cognition

Kushigian DJ, Vaou OE.

Nutr Neurosci. 2024 May;27(5):506-519. doi: 10.1080/1028415X.2023.2228561. Epub 2023 Jul 3.

Detection and prediction of freezing of gait with wearable sensors in Parkinson's disease

Zhang W, Sun H, Huang D, Zhang Z, Li J, Wu C, Sun Y, Gong M, Wang Z, Sun C, Cui G, Guo Y, Chan P.

Neurol Sci. 2024 Feb;45(2):431-453. doi: 10.1007/s10072-023-07017-y. Epub 2023 Oct 16.

Modeling familial and sporadic Parkinson's disease in small fishes

Yamanaka T, Matsui H.

Dev Growth Differ. 2024 Jan;66(1):4-20. doi: 10.1111/dgd.12904. Epub 2023 Dec 11.

Neuroactive steroids and Parkinson's disease: Review of human and animal studies

Bourque M, Morissette M, Di Paolo T.

Neurosci Biobehav Rev. 2024 Jan;156:105479. doi: 10.1016/j.neubiorev.2023.105479. Epub 2023 Nov 23.

Delivery of Allied Health Therapies to People with Parkinson's Disease in Africa

Cilia R, Dekker MCJ, Cubo E, Agoriwo MW.

J Parkinsons Dis. 2024;14(s1):S227-S239. doi: 10.3233/JPD-230262.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias